Advarra Videos

  1. Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements 2/9/2026

    In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).

  2. Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design 1/28/2026

    Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

  3. How To Drive Stronger Sponsor-Site Partnerships 4/25/2025

    Karri Venn of SCRS discussed the value of deep partnerships, referencing a Sanofi initiative (SMILE) that trusted sites with protocol input and offered maximum budgets without negotiation.

  4. How Sites Are Often Evaluated By Sponsors 4/25/2025

    Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study.

  5. Why Relationship-Building Is The Hardest Part Of Site Success 4/25/2025

    Site owner Devora Henderson of Elevate Clinical Research reflected on her experience launching two site networks.

  6. How Merck Enhances Site Collaboration 4/25/2025

    Learn about Merck’s approach to fostering strong site relationships through specialty roles like institutional lead CRAs and site relationship managers.

  7. What Boosts Efficiency At Smaller Clinical Sites? 4/25/2025

    Devora Henderson, CEO of Elevate Clinical Research, highlighted the need for clear points of contact at smaller sites.

  8. Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency 4/25/2025

    Karri Venn, VP site advocacy and mentorship at SCRS, emphasized the importance of sponsors recognizing the structure and capabilities of larger site networks.

  9. Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials 1/30/2025

    Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.

  10. Strategies For Research Institutions In An Evolving Era Of Oncology 11/11/2024

    As biomarker-directed therapies drive advancements in the oncology space, experts are reviewing cutting-edge trends and strategies that help institutions address ethical and regulatory challenges.